514 related articles for article (PubMed ID: 20166879)
21. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.
Oliveira VG; Caridade M; Paiva RS; Demengeot J; Graca L
Eur J Immunol; 2011 May; 41(5):1249-55. PubMed ID: 21469093
[TBL] [Abstract][Full Text] [Related]
22. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
Wang J; Huizinga TW; Toes RE
J Immunol; 2009 Sep; 183(6):4119-26. PubMed ID: 19717521
[TBL] [Abstract][Full Text] [Related]
23. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
[TBL] [Abstract][Full Text] [Related]
24. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
[TBL] [Abstract][Full Text] [Related]
25. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
26. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.
Larmonier N; Marron M; Zeng Y; Cantrell J; Romanoski A; Sepassi M; Thompson S; Chen X; Andreansky S; Katsanis E
Cancer Immunol Immunother; 2007 Jan; 56(1):48-59. PubMed ID: 16612596
[TBL] [Abstract][Full Text] [Related]
27. IL-27 inhibits the development of regulatory T cells via STAT3.
Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
[TBL] [Abstract][Full Text] [Related]
28. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
30. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
Zhang L; Yi H; Xia XP; Zhao Y
Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
[TBL] [Abstract][Full Text] [Related]
32. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
Lei J; Hasegawa H; Matsumoto T; Yasukawa M
J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
[TBL] [Abstract][Full Text] [Related]
34. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
Yang Y; Paik JH; Cho D; Cho JA; Kim CW
Int Immunopharmacol; 2008 Apr; 8(4):542-7. PubMed ID: 18328445
[TBL] [Abstract][Full Text] [Related]
36. CD4+ Foxp3+ regulatory T cells mediate Toxoplasma gondii-induced T-cell suppression through an IL-2-related mechanism but independently of IL-10.
Tenorio EP; Fernández J; Castellanos C; Olguín JE; Saavedra R
Eur J Immunol; 2011 Dec; 41(12):3529-41. PubMed ID: 21905022
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells.
Moreira-Teixeira L; Resende M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC
J Immunol; 2012 Jan; 188(2):624-31. PubMed ID: 22156591
[TBL] [Abstract][Full Text] [Related]
38. Identification of regulatory T cells during experimental Leishmania infantum infection.
Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM
Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.
Wahl SM; Chen W
Arthritis Res Ther; 2005; 7(2):62-8. PubMed ID: 15743491
[TBL] [Abstract][Full Text] [Related]
40. Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Zhao GJ; Lu ZQ; Tang LM; Wu ZS; Wang DW; Zheng JY; Qiu QM
Int Immunopharmacol; 2012 Sep; 14(1):99-106. PubMed ID: 22749847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
